Prescribing Safety Assessment (PSA) Practice Exam

Which medication is part of the MONABASH protocol for NSTEMI management?

1. Metoprolol

2. Bisoprolol

3. Atenolol

4. Propranolol

The correct answer is: Bisoprolol

The MONABASH protocol is a set of guidelines for the management of patients diagnosed with non-ST-elevation myocardial infarction (NSTEMI). One of the key components of this protocol is the use of beta-blockers to improve outcomes in these patients. Bisoprolol is specifically included in the MONABASH protocol due to its cardiovascular benefits, such as reducing heart rate, blood pressure, and myocardial oxygen demand, which can be crucial in managing NSTEMI. Bisoprolol has been shown to have a favorable profile in terms of efficacy and tolerability among various beta-blockers, making it a preferred option in this context. It helps to mitigate the risk of further cardiac events and improve overall cardiac function post-NSTEMI. The selection of bisoprolol reflects the importance of utilizing medications that have strong evidence supporting their use in this specific clinical scenario, as outlined in the MONABASH protocol. Other beta-blockers, while beneficial in various scenarios, may not be as prominently featured in this specific protocol. Each medication may vary in terms of pharmacokinetics, side effect profiles, and associated clinical outcomes in the population of patients who experience NSTEMI. Hence, bisoprolol stands out in the context of